In Vitro Model for Analysis of High-Flow Aerosol Delivery During Continuous Nebulization
Respiratory Care · 2023
DOI: 10.4187/respcare.10643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respiratory Care, 2023. Verfasst von Michael McPeck und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary, Critical Care and Sleep Medicine Division, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York. Hauptthemen laut MEDLINE: Bronchodilator Agents, Albuterol. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pulmonary, Critical Care and Sleep Medicine Division, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York.
- Pulmonary, Critical Care and Sleep Medicine Division, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York. gerald.smaldone@stonybrook.edu.
Zitieren
APA
McPeck, M., Moon, J., Jayakumaran, J., & Smaldone, G. C. (2023). In Vitro Model for Analysis of High-Flow Aerosol Delivery During Continuous Nebulization. Respiratory Care. https://doi.org/10.4187/respcare.10643
Vancouver
McPeck M, Moon J, Jayakumaran J, Smaldone GC. In Vitro Model for Analysis of High-Flow Aerosol Delivery During Continuous Nebulization. Respiratory Care. 2023. doi:10.4187/respcare.10643
BibTeX
@article{McPeck2023,
author = {McPeck, Michael and Moon, Jane and Jayakumaran, Jeyanthan and Smaldone, Gerald C},
title = {In Vitro Model for Analysis of High-Flow Aerosol Delivery During Continuous Nebulization},
journal = {Respiratory Care},
year = {2023},
doi = {10.4187/respcare.10643}
}
EUVIMED